Goedgekeurde dataverzoeken

 

  1. R. van Boxtel, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  2. R. Bernards, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Carcinogenesis
  3. F. Weeber, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  4. W. Kloosterman, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  5. H. van Snellenberg, Hartwig Medical Foundation, for the purpose of the collaboration with Hartwig Medical Foundation Australia
  6. S. Groenland, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Medical Oncology and Clinical Pharmacology
  7. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  8. J. Aerts, Erasmus Medical Center, section Lung Diseases
  9. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  10. E. Cuppen / R. Koster, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  11. M. Lolkema, Erasmus Medical Center, section Internal Oncology
  12. H. Verheul / C. Jimenez, VU University Medical Center, section Medical Oncology
  13. M. van der Heijden, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Carcinogenesis
  14. J. Martens, Erasmus Medical Center, section Internal Oncology
  15. L. Hoes, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Molecular Oncology
  16. R. Fijneman, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Pathology
  17. N. Lopez Bigas, Institute for Research in Biomedicine (Barcelona), Genomics
  18. E. Cuppen, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  19. E. Cuppen, University Medical Center Utrecht, Center for Molecular Medicine, section Genetics
  20. P. van Diest, University Medical Center Utrecht, Pathology
  21. S. Nik-Zainal, University of Cambridge, Academic Department of Medical Genetics
  22. E. Voest, Netherlands Cancer Institute – Antoni van Leeuwenhoek, section Molecular Oncology and Immunology
  23. N. Lopez Bigas, IRB Barcelona, Biomedical Genomics
  24. K. Zwinderman, Academic Medical Center, Oncogenomics / KEBB
  25. J. Martens, Erasmus Medical Center, section Internal Oncology